Survival and DFS after BMT for CML: multivariate analyses
| . | Relative risk (95% CI) . | P . |
|---|---|---|
| Survival3-150 | ||
| MSD | 1.0 | — |
| URD matched | 1.89 (1.59-2.25) | .0001 |
| URD partially matched | 2.74 (2.25-3.35) | .0001 |
| Chronic phase | 1.0 | — |
| Accelerated phase/remission postblast phase | 1.52 (1.35-1.70) | .0001 |
| Blast phase | 2.47 (2.04-2.99) | .0001 |
| Older recipient age, per decade | 1.17 (1.11-1.23) | .0001 |
| Older donor age, per decade | 1.08 (1.02-1.14) | .009 |
| Recipient CMV-seropositive | 1.17 (1.06-1.30) | .002 |
| Time to BMT more than 1 year | 1.34 (1.20-1.51) | .0001 |
| DFS3-151 | ||
| MSD | 1.0 | — |
| URD matched | 1.82 (1.53-2.16) | .0001 |
| URD partially matched | 2.66 (2.18-3.25) | .0001 |
| Chronic phase | 1.0 | — |
| Accelerated phase/remission postblast phase | 1.58 (1.41-1.78) | .0001 |
| Blast phase | 2.67 (2.20-3.24) | .0001 |
| Older recipient age, per decade | 1.18 (1.12-1.24) | .0001 |
| Older donor age, per decade | 1.05 (0.99-1.11) | .09 |
| Recipient CMV-seropositive | 1.17 (1.05-1.30) | .004 |
| Time to BMT more than 1 year | 1.33 (1.18-1.49) | .0001 |
| . | Relative risk (95% CI) . | P . |
|---|---|---|
| Survival3-150 | ||
| MSD | 1.0 | — |
| URD matched | 1.89 (1.59-2.25) | .0001 |
| URD partially matched | 2.74 (2.25-3.35) | .0001 |
| Chronic phase | 1.0 | — |
| Accelerated phase/remission postblast phase | 1.52 (1.35-1.70) | .0001 |
| Blast phase | 2.47 (2.04-2.99) | .0001 |
| Older recipient age, per decade | 1.17 (1.11-1.23) | .0001 |
| Older donor age, per decade | 1.08 (1.02-1.14) | .009 |
| Recipient CMV-seropositive | 1.17 (1.06-1.30) | .002 |
| Time to BMT more than 1 year | 1.34 (1.20-1.51) | .0001 |
| DFS3-151 | ||
| MSD | 1.0 | — |
| URD matched | 1.82 (1.53-2.16) | .0001 |
| URD partially matched | 2.66 (2.18-3.25) | .0001 |
| Chronic phase | 1.0 | — |
| Accelerated phase/remission postblast phase | 1.58 (1.41-1.78) | .0001 |
| Blast phase | 2.67 (2.20-3.24) | .0001 |
| Older recipient age, per decade | 1.18 (1.12-1.24) | .0001 |
| Older donor age, per decade | 1.05 (0.99-1.11) | .09 |
| Recipient CMV-seropositive | 1.17 (1.05-1.30) | .004 |
| Time to BMT more than 1 year | 1.33 (1.18-1.49) | .0001 |